Motoyuki Suzuki
Department Of Otorhinolaryngology Head And Neck Surgery
Suita, Japan
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Serum lactate dehydrogenase to alanine aminotransferase ratio as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Journal: Acta oto-laryngologica
Published: March 11, 2026
Radiation-Induced Volume Changes in the Parotid and Submandibular Glands, Intragland Dose Distribution, and Quality of Life Scores Over a Long Follow-Up Period.
Journal: Advances in radiation oncology
Published: January 14, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study).
Journal: International journal of clinical oncology
Published: August 01, 2025
Anemia, as an adverse event during chemoradiotherapy for head and neck cancer, contributes to a reduction in swallowing muscle mass and leads to dysphagia.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 22, 2025
Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Journal: Acta oto-laryngologica
Published: August 10, 2024
Feasibility and safety of endoscopic submucosal dissection for superficial cancer of the remnant esophagus after esophagectomy.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: July 11, 2024
Changes in swallowing response on patients undergoing chemoradiotherapy for head and neck cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 03, 2024
Last Updated: 09/26/2026